Camille Jacques

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Oxidative Stress

Natural Killer Cells

Top Venues

International journal of molecular sciences

Life (Basel, Switzerland)

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Ilaria Floris
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients. Life (Basel, Switzerland) 14 (1) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Ilaria Floris
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients. Life (Basel, Switzerland) 14 (1) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Mathieu Riffault, Ilaria Floris
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy. Life (Basel, Switzerland) 14 (3) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
The Micro-Immunotherapy Medicine 2LPAPI ® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells. Cancers 16 (7) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Mathieu Riffault, Ilaria Floris
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy. Life (Basel, Switzerland) 14 (3) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
The Micro-Immunotherapy Medicine 2LPAPI ® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells. Cancers 16 (7) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Ilaria Floris
Actives from the Micro-Immunotherapy Medicine 2LMIREG ® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function. Journal of inflammation research 17 (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
The Micro-Immunotherapy Medicine 2LPAPI ® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells. Cancers 16 (7) (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Ilaria Floris
Actives from the Micro-Immunotherapy Medicine 2LMIREG ® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function. Journal of inflammation research 17 (2024)
Camille Jacques, Flora Marchand, Mathias Chatelais, Adrien Brulefert, Ilaria Floris
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients. Life (Basel, Switzerland) 14 (1) (2024)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Ilaria Floris
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March. International journal of molecular sciences 24 (2) (2023)
Camille Jacques, Mathias Chatelais, Karim Fekir, Adrien Brulefert, Ilaria Floris
The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell Types. International journal of molecular sciences 23 (4) (2022)
Camille Jacques, Ilaria Floris
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts. Journal of inflammation research 15 (2022)
Camille Jacques, Irene Marchesi, Francesco Paolo Fiorentino, Mathias Chatelais, Nicoletta Libera Lilli, Kurt Appel, Beatrice Lejeune, Ilaria Floris
A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model. International journal of molecular sciences 23 (11) (2022)
Camille Jacques, Ilaria Floris
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts. Journal of inflammation research 15 (2022)